Twitter LinkedIn
    Wednesday, October 4
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Biotechnology»Warburg and Advent in the lead to acquire Baxter’s biopharma unit
    Biotechnology

    Warburg and Advent in the lead to acquire Baxter’s biopharma unit

    May 13, 2023Updated:May 13, 20231 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s (BAX.N) biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday.

    Warburg Pincus and Advent have submitted the most attractive offer to Baxter in an auction that drew interest from other private equity firms as well as major players in the biomedical sector such as Thermo Fisher Scientific Inc (TMO.N), the sources said.

    The buyout consortium has turned to other private equity firms to help fund the deal as direct lenders, one of the sources added.

    There is no certainty that Warburg Pincus and Advent will successfully complete negotiations to acquire the unit and Baxter may still opt to sell to another bidder or keep the business, according to the sources. They requested anonymity because details of the sale process are confidential.

    Read more: Reuters

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Animal drugs maker Dechra agrees to lower £4.5bn takeover by Swedish private equity firm EQT

    June 3, 2023

    BlackRock Sells Asset-Backed Bonds From Credit Suisse’s Books

    April 14, 2023

    KKR buys stake in communications firm FGS Global

    April 11, 2023

    Parthenon Capital closes Fund VII at $4.5bn

    April 3, 2023

    Comments are closed.

    Other Articles

    VEGAMOUR announces USD80m minority growth investment by General Atlantic

    April 14, 2021

    Pathstone to acquire $3.5B Dyson Capital Advisors

    July 14, 2022

    Thoma Bravo joins PeakEquity, C&B with Grayshift investment

    June 23, 2022

    Goldman Sachs chases stake in £700m financial advice platform Nucleus

    March 11, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?